Citadel Advisors’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$3.22K 13606
2025
Q1
$3.22K Sell
100
-1,900
-95% -$61.6K ﹤0.01% 13981
2024
Q4
$63.6K Hold
2,000
﹤0.01% 12112
2024
Q3
$57.7K Sell
2,000
-8,100
-80% -$232K ﹤0.01% 11753
2024
Q2
$282K Buy
10,100
+9,500
+1,583% +$253K ﹤0.01% 9263
2024
Q1
$16K Sell
600
-300
-33% -$8.03K ﹤0.01% 13155
2023
Q4
$24.3K Sell
900
-200
-18% -$4.97K ﹤0.01% 12455
2023
Q3
$23.7K Buy
+1,100
New +$24.3K ﹤0.01% 12483
2023
Q1
Sell
-100
Closed -$2.48K 15036
2022
Q4
$2.48K Buy
+100
New +$2.4K ﹤0.01% 14329

Other funds holding HSTM

Citadel Advisors's HSTM Position: Q2 2026 in Review

Citadel Advisors reduced its HealthStream (HSTM) stake by 87% in Q2 2026, selling an estimated $1.6M and leaving 10,383 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #11241.

Citadel Advisors first reported a position in HSTM in Q4 2013 and has held it in 50 quarters since. The position peaked at $4.92M in Q2 2024. 219 funds tracked by Wall St. Rank hold HSTM as of Q2 2026.

  • Citadel Advisors held 10,383 shares of HealthStream worth $283K as of Q2 2026.
  • Citadel Advisors sold 68,382 HealthStream shares in Q2 2026, an estimated $1.6M.
  • HealthStream made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11241 holding.
  • Citadel Advisors first reported a position in HealthStream in Q4 2013 and has held it in 50 quarters since.
  • Citadel Advisors's HealthStream position peaked at $4.92M in Q2 2024.
  • 219 funds tracked by Wall St. Rank held HealthStream as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.